On Aug. 12, 2020, Celdara Medical announced that the NIH had awarded a Small Business Innovation Research (SBIR) grant to fund the company’s development of advanced antivirals for the treatment of pandemic and interpandemic influenza. Celdara Medical initiated this work in 2014.